Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Xianhong Liu"'
Autor:
Xianhong Liu, Jing Chen, Shaoyu Yue, Cheng Zhang, Jian Song, Hu Liang, Chaozhao Liang, Xianguo Chen
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-16 (2024)
Abstract Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a urinary disorder that affects youthful to middle-aged men most frequently. It has been revealed that Th17/Treg imbalance is a crucial factor in the pathophysiological mechanisms
Externí odkaz:
https://doaj.org/article/38be4b7cecce492495f13aa6e5a93b57
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
BackgroundChronic Kidney Disease (CKD) stands as a formidable health challenge, recognized not only for its growing prevalence but also for its association with elevated mortality rates. Emerging evidence suggests that CKD is inherently linked to inf
Externí odkaz:
https://doaj.org/article/22eff17872a647c79bdf71541585e58e
Autor:
Liang Zhang, Lianwei Bai, Xianhong Liu, Ying Liu, Shuang Li, Jingjing Liu, Shuang Zhang, Changliang Yang, Xiubao Ren, Ying Cheng
Publikováno v:
Thoracic Cancer, Vol 11, Iss 5, Pp 1170-1179 (2020)
Abstract Background Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of non‐small cell lung cancer (NSCLC). While rapid progression (RP) has been proposed as a non‐negligible pattern of response to ICIs, its definition and re
Externí odkaz:
https://doaj.org/article/7274abe1bc5c4977aef1fe4df7724dc3
Publikováno v:
Chinese Journal of Lung Cancer, Vol 21, Iss 11, Pp 821-827 (2018)
Background and objective Epidermal growth factor receptor (EGFR)-based targeted therapy improves the survival of patients with advanced lung adenocarcinoma harboring EGFR mutations. However, factors including treatment or heterogeneity partly contrib
Externí odkaz:
https://doaj.org/article/91408297a0ff4ef3b255cc30f9d736b5
Autor:
Jing Wang, Huajie Lv, Zhuang Luo, Shan Mou, Jing Liu, Chang Liu, Shiying Deng, Youfan Jiang, Jiachen Lin, Chengzhou Wu, Xianhong Liu, Jinzhi He, Depeng Jiang
Publikováno v:
Respiratory Research, Vol 19, Iss 1, Pp 1-10 (2018)
Abstract Background Asthma-chronic obstructive pulmonary disorder (COPD) overlap (ACO) is characterized by the coexistence of features of both asthma and COPD and is associated with rapid progress and a poor prognosis. Thus, the early recognition of
Externí odkaz:
https://doaj.org/article/cc6c8b6785f14793b6a085b62d199542
Publikováno v:
Chinese Journal of Lung Cancer, Vol 17, Iss 8, Pp 588-595 (2014)
Background and objective Small cell lung cancer accounts for about 15%-25% of lung cancer, although the new chemotherapy drugs and radiation technology are continuously progressing, but the prognosis is still poor. To explore the prognostic factor of
Externí odkaz:
https://doaj.org/article/4280f6b0ef994fc889391b7100f1ce10
Publikováno v:
Cancer Management and Research. 12:12697-12708
Purpose Recent studies have identified important roles for long intergenic non-protein coding RNA 1426 (LINC01426) in glioma and clear cell renal cell carcinoma. The present study evaluated the expression profile of LINC01426 in non-small cell lung c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1fdfdf678b17c8630b63ee34024b9966
https://doi.org/10.2147/cmar.s277113
https://doi.org/10.2147/cmar.s277113
Publikováno v:
Risk Management and Healthcare Policy. 13:2371-2377
Background Cardiovascular diseases (CVDs) are the main cause of death in patients with chronic kidney disease (CKD). Interleukin-4 (IL-4) is considered an inflammatory cytokine. However, few studies have investigated the association between serum IL-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c9102f6e88e79e6b83631ffe17e1915
https://doi.org/10.2147/rmhp.s270845
https://doi.org/10.2147/rmhp.s270845
Autor:
Shuang Li, Xianhong Liu, Liang Zhang, Ying Cheng, Xiubao Ren, Shuang Zhang, Jingjing Liu, Ying Liu, Lianwei Bai, Changliang Yang
Publikováno v:
Thoracic Cancer, Vol 11, Iss 5, Pp 1170-1179 (2020)
Thoracic Cancer
Thoracic Cancer
Background Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of non‐small cell lung cancer (NSCLC). While rapid progression (RP) has been proposed as a non‐negligible pattern of response to ICIs, its definition and related fac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3a52d8e5cb0093c2239f33989079571
https://doi.org/10.1111/1759-7714.13370
https://doi.org/10.1111/1759-7714.13370
Publikováno v:
Cancer Management and Research
Yan Liu,1 Hui Li,1 Jing Zhu,2 Yang Zhang,2 Xianhong Liu,2 Rixin Li,1 Qiang Zhang,3 Ying Cheng1,2 1Medical Oncology Translational Research Lab, Jilin Provincial Key Laboratory of Molecular Diagnostics for Lung Cancer, Jilin Cancer Hospital, Changchun,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a60b8a2056392154021cb71652b3d33
https://www.dovepress.com/the-prevalence-and-concurrent-pathogenic-mutations-of-krasg12c-in-nort-peer-reviewed-article-CMAR
https://www.dovepress.com/the-prevalence-and-concurrent-pathogenic-mutations-of-krasg12c-in-nort-peer-reviewed-article-CMAR